The proposal directs 100% of application and product revenue back to AAVE token holders, resolving a governance dispute that began when swap fees were quietly redirected away from the DAO treasury in late 2025.Tech, NewsRead More

You might also be interested in reading Apyx Medical outlines $50M–$52M 2025 revenue targets as AYON presales surpass expectations and China launch advances.